May 6, 2015 - This report provides an in-depth look at regenerative medicine and advanced therapies sector trends and metrics compiled from more than 580 leading therapeutic companies worldwide.

Register today to join us on June 9 & 10 to celebrate the past year's accomplishments in our sector, hear from advanced therapies' top executives, policy leaders and patients and stand with fellow ARM members to advocate for legislation that will lead to live-saving technologies.

While in Philadelphia for the BIO International Convention, join ARM on Monday, June 15 for a private evening reception bringing together key stakeholders representing the regenerative medicine and advanced therapies community.

About ARM

Advancing Regenerative Medicine
The Alliance for Regenerative Medicine (ARM) is a Washington, DC-based multi-stakeholder advocacy organization that promotes legislative, regulatory and reimbursement initiatives necessary to facilitate access to life-giving advances in regenerative medicine. ARM also works to increase public understanding of the field and its potential to transform human healthcare, providing business development and investor outreach services to support the growth of its member companies and research organizations.
Learn more

Our Members

200+ and Growing
ARM’s membership is diverse, representing leading regenerative medicine companies and investors, university-based and non-profit research institutions, patient advocacy groups, pharmaceutical companies engaged in regenerative medicine research and other organizations supporting regenerative medicine.
Learn more